Amir Abbas Tahami Monfared

Application of lag‐time into exposure definitions to control for protopathic bias

Hani Tamim, Amir Abbas Tahami Monfared, Jacques LeLorier · Pharmacoepidemiology and Drug Safety · 2007 · 162 citations

Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes

Ron Goeree, Julie Villeneuve, Jeff Goeree et al. · Journal of Medical Economics · 2016 · 77 citations

Cancer Management, Prognosis, Clinical Endpoint +17

Pain and Quality of Life Assessment after Endovascular Versus Open Repair of Abdominal Aortic Aneurysms in Patients at Low Risk

Gilles Soulez, Éric Thérasse, Amir Abbas Tahami Monfared et al. · Journal of Vascular and Interventional Radiology · 2005 · 66 citations

Life Assessment, Endovascular Technique, Low Risk +8

Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation

Ian Koblbauer, Najida Begum, George Dranitsaris et al. · PharmacoEconomics · 2017 · 64 citations · Full text

Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling

Amir Abbas Tahami Monfared, Ali Tafazzoli, Weicheng Ye et al. · Neurology and Therapy · 2022 · 57 citations · Full text